Education
He studied veterinary medicine at university (École nationale vétérinaire d"Alfort at Maisons-Alfort in south-east Paris). He later studied at Higher Education Commission Paris.
He studied veterinary medicine at university (École nationale vétérinaire d"Alfort at Maisons-Alfort in south-east Paris). He later studied at Higher Education Commission Paris.
Roussel Uclaf
In April 1986, he joined Roussel Uclaf (formerly France"s second largest pharmaceutical company, until bought by Hoechst AG in 1997) as a salesman, where he lived in Australia. In 1996 he became General Manager of Hoechst Marion Roussel in Australia, moving to Tokyo in April 1997
Aventis
In 2000 he moved to Aventis in America, becoming Chief Operating Officer of Aventis United States of America in 2002, which became Sanofi Aventis United States of America in 2004. Roche
He joined Roche in 2006.
From April 2009 to 2010 he was Chief Executive of the Roche subsidiary Genentech.
He rejoined Roche Pharma AG in 2010 as Chief Operating Officer. AstraZeneca
On 28 August 2012 he was named as the new Chief Executive of AstraZeneca, the world"s fifth largest pharmaceutical company, when aged 53.
He took up the post on 1 October 2012.